FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

The FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction
• Peripheral Artery Disease
• Stable Angina
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Plavix (clopidogrel)

Snippet

SUPPL AP for PLAVIX (CLOPIDOGREL)